Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics

Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines

(2014) Thomas C. Newton et al.   Translational Oncology

Tumor-Initiating Cells in Childhood Neuroblastoma--Letter

(2012) S. Mohlin et al.   CANCER RESEARCH

Direct Reprogramming of Mouse and Human Fibroblasts into Multipotent Neural Stem Cells with a Single Factor

(2012) Karen L. Ring et al.   Cell Stem Cell

Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma

(2012) Sonia Cournoyer et al.   GENES CHROMOSOMES & CANCER

CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway

(2012) Hervé Sartelet et al.   HISTOPATHOLOGY

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

(2012) Philipp Grosse-Gehling et al.   JOURNAL OF PATHOLOGY

A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat

(2011) Till Milde et al.   ACTA NEUROPATHOLOGICA

ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux

(2011) Michelle J. Henderson et al.   JNCI-Journal of the National Cancer Institute

T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications

(2011) F. Lluis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD133 expression in chemo-resistant Ewing sarcoma cells

(2010) Xiaohua Jiang et al.   BMC CANCER

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

(2010) Bin Zhang et al.   CANCER CELL

Metastatic cancer stem cells: A new target for anti-cancer therapy?

(2010) Patrick C. Hermann et al.   CELL CYCLE

Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells

(2010) Giovanni Di Bernardo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

CD13 is a therapeutic target in human liver cancer stem cells

(2010) Naotsugu Haraguchi et al.   JOURNAL OF CLINICAL INVESTIGATION

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

(2010) Anna Maria Calcagno et al.   JNCI-Journal of the National Cancer Institute

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

(2010) H Takenobu et al.   ONCOGENE

Histone deacetylase inhibitors as anti-neoplastic agents

(2009) Nicolas Batty et al.   CANCER LETTERS

Identification of Cancer Stem Cells in Ewing's Sarcoma

(2009) M.-L. Suva et al.   CANCER RESEARCH

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

(2009) N. A. Dallas et al.   CANCER RESEARCH

Cancer Stem Cells: The Emerging Challenge of Drug Targeting

(2009) Roger Besancon et al.   CURRENT MEDICINAL CHEMISTRY

Role for notch signaling in salivary acinar cell growth and differentiation

(2009) Howard Dang et al.   DEVELOPMENTAL DYNAMICS

Stem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells

(2009) Yi Liang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ABC Transporters, Drug Resistance, and Cancer Stem Cells

(2009) Michael Dean   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents

(2009) Sharada D. Vangipuram et al.   PEDIATRIC BLOOD & CANCER

Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus

(2009) Yonatan Y. Mahller et al.   PLoS One

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

lumi: a pipeline for processing Illumina microarray

(2008) P. Du et al.   BIOINFORMATICS

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

(2008) S. Zhang et al.   CANCER RESEARCH

Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency

(2008) Alexander Marson et al.   Cell Stem Cell

Prostate cancer stem cells

(2008) SH Lang et al.   JOURNAL OF PATHOLOGY

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

(2008) T Baba et al.   ONCOGENE

Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population

(2008) Sebastian C.J. Steiniger et al.   STEM CELLS